Skip to Main Content

Paper Details

Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis: an open-label, phase 2 trial.
Res Sq
0
2023
B cell, B cell malignancies, BTK, Bruton's tyrosine kinase, IgE, IgE-mediated anaphylaxis, IgE-mediated peanut allergy, acalabrutinib, allergic reactions, anaphylaxis, patients, peanut, systemic allergic reaction, tyrosine
Author NameAffiliation
Dhananjay VaidyaJohns Hopkins University School of Medicine
Robert A WoodJohns Hopkins University School of Medicine
Bruce S BochnerNorthwestern University Feinberg School of Medicine
  • 1 - 3

Datasets

Release 1.2